Search - tctmd.com

Displaying 101 - 120 of 213

Sort: Relevancy | Date

Presentation TCT 2019

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Presenter: Philipp Lurz

September 28, 2019

Presentation TCT 2019

Innovative Trial Designs in Device-Based Hypertension Treatment

Presenter: Konstantinos Tsioufis

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presentation TCT 2019

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presenter: Bernard Gersh

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presentation TCT 2019

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Presenter: Naomi Fisher

September 28, 2019

Presentation TCT 2019

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Presenter: Daniel Burkhoff

September 28, 2019

Presentation TCT 2019

Update on ROX Trial Program (AV Fistula Creation)

Presenter: Melvin Lobo

September 28, 2019

Presentation TCT 2019

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Presenter: Justin Davies

September 28, 2019

Presentation TCT 2019

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Michael Boehm

September 28, 2019

Presentation TCT 2019

Patient Preferences in Hypertension Treatment

Presenter: David Kandzari

September 28, 2019

Presentation TCT 2019

Non-Adherence in Uncontrolled Hypertension: How to Assess and Manage?

Presenter: Roland Schmieder

September 28, 2019

Presentation TCT 2019

Race-Based Differences in Hypertension Management: What’s Relevant?

Presenter: Clyde Yancy

September 28, 2019

Presentation TCT 2019

Sex-Based Differences in Hypertension Management: Do They Exist?

Presenter: Ileana Pina

September 28, 2019

Presentation TCT 2019

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

Presenter: Michael Weber

September 28, 2019

Presentation TCT 2019

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Presenter: Andrew Sharp

September 28, 2019

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Todd Neale

June 24, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

Advertisement

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Innovative Trial Designs in Device-Based Hypertension Treatment

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Update on ROX Trial Program (AV Fistula Creation)

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Patient Preferences in Hypertension Treatment

Non-Adherence in Uncontrolled Hypertension: How to Assess and Manage?

Race-Based Differences in Hypertension Management: What’s Relevant?

Sex-Based Differences in Hypertension Management: Do They Exist?

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content